Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01070121 · ClinicalTrials.gov registry record
Treatment Efficacy and Toxicity in Rheumatoid Arthritis Database and Repository
A clinical trial of Rheumatoid Arthritis, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 200
- Enrollment target
- 9
- Study locations
NCT01070121 is a study of Rheumatoid Arthritis that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 200 participants, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (96% lower). The trial reports 9 study locations across 9 states.
The verdict
NCT01070121, a study of Rheumatoid Arthritis, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
- 9
- Study locations
Study Summary
To stimulate collaborative efforts of federal funding agencies, voluntary health agencies, professional organizations and industry partners to enable creation of a large, sustainable database and repository to better understand the molecular basis of treatment and rapidly accelerate translational research in RA.
Conditions Studied
Study Locations (9)
Alabama
- University of Alabama at Birmingham - Birmingham
California
- Stanford University - Palo Alto
Colorado
- University of Colorado in Denver - Aurora
Maryland
- Johns Hopkins University - Baltimore
Massachusetts
- Brigham and Women's Hospital - Boston
Nebraska
- University of Nebraska Medical Center - Omaha
New York
- North Shore Medical Center (LIJ Health System) - Lake Success
North Carolina
- Duke University - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2010-02 |
| Est. Completion | 2012-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01070121
The ClinicalTrials.gov registry entry for NCT01070121 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (96% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 0 interventions.
NCT01070121 reports 9 study locations spanning 9 distinct geographic areas - top geographies include Alabama, California, Colorado.
Frequently Asked Questions
What is clinical trial NCT01070121 about?
NCT01070121 is a clinical study titled "Treatment Efficacy and Toxicity in Rheumatoid Arthritis Database and Repository". To stimulate collaborative efforts of federal funding agencies, voluntary health agencies, professional organizations and industry partners to enable creation of a large, sustainable database and repository to better understand the molecular basis of treatment and rapidly accelerate translational re...
What is the current status of trial NCT01070121?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2010-02. Estimated completion is 2012-08.
What conditions does trial NCT01070121 study?
This clinical trial studies the following conditions: Rheumatoid Arthritis.
Who is sponsoring clinical trial NCT01070121?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01070121 being conducted?
This trial has 9 study locations across Alabama, California, Colorado, Maryland, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rheumatoid Arthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Rheumatology Diet Study
RECRUITING
-
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
RECRUITING · Phase 1
-
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
RECRUITING · NA
-
Creating Health Course Study for People With Rheumatological Conditions
RECRUITING · NA
-
Physica System Total Knee Replacement Registry Study
RECRUITING · NA
-
Study of GS-0151 in Participants With Rheumatoid Arthritis
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.